Encore Dermatology Inc. Announces Launch of TridesilonTM (desonide) Cream, 0.05%

Malvern, PA, January 17, 2017

Encore Dermatology Inc., a privately held dermatology 
company that specializes in developing and commercializing novel prescription products for improving skin health, announced today the availability of TridesilonTM (desonide) Cream, 0.05% 
in a 60g tube. TridesilonTM Cream, 0.05% is a low-potency corticosteroid indicated for the
 relief of the inflammatory and pruritic manifestations of corticosteroid-responsive 
dermatoses.

Encore Dermatology, Inc. Announces Launch of HylatopicPlus® Lotion

Malvern, PA, Oct. 13, 2016

Encore Dermatology, Inc., a leader in developing and commercializing novel, prescription products for improving skin health, today announced the availability of HylatopicPlus® Lotion in a convenient 14 oz. bottle with pump dispenser.

Encore Dermatology, Inc., A New Specialty Dermatology Company

Malvern, PA, May 18, 2015

Encore Dermatology, Inc. announced today that it has begun to commercialize HylatopicPlus® and Tetrix®, two highly regarded and established U.S. topical dermatology products acquired from Valeant Pharmaceuticals North America, LLC and certain of its affiliates.

 

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save